3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success Story - B&C-Gruppe

Von einem Mystery-Man-Autor
Last updated 09 Juni 2024
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
Institution: University of Natural Resources and Life Sciences, Vienna (BOKU), Department of Biotechnology Project lead: DI Miriam Klausberger, Ph.D., DI Mark Dürkop, Ph.D. Project description (German): Ein SARS-CoV-2-Antikörpertest gibt Auskunft darüber, ob jemand bereits mit dem Coronavirus infiziert war oder ob im Rahmen einer Impfung Antikörper gebildet wurden. Für den Antikörpernachweis nach einer Infektion oder […]
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
Overview of ELISA Testing for COVID-19 Antibodies
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
COVID-19 Testing Kits
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
Biosensors based on potent miniprotein binder for sensitive testing of SARS- CoV‑2 variants of concern
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications - IOS Press
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
Viruses January 2022 - Browse Articles
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications - IOS Press
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
bntx-20211231
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
Antibody-Free Rapid Detection of SARS-CoV-2 Proteins Using Corona Phase Molecular Recognition to Accelerate Development Time
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
Houska Prize - B&C Gruppe
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study - eBioMedicine
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools by means of agent-based simulations calibrated to cluster tracing data
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications - IOS Press

© 2014-2024 esfamim.com. Inc. or its affiliates.